BVS Q4 2023 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$135M+7.6% YoY

Gross Profit

$86M63.7% margin

Operating Income

$1M0.9% margin

Net Income

-$6M-4.5% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+12.1%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$811M

Total Liabilities

$590M

Stockholders' Equity

$174M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$135M	$126M	+7.6%
Gross Profit	$86M	$74M	+16.3%
Operating Income	$1M	-$25M	+104.6%
Net Income	-$6M	-$32M	+80.9%

Geographic Segments

UNITED STATES

$209M89%

Non-US

$27M11%